Publication:
Schimke immunoosseous dysplasia: defining skeletal features

dc.contributor.authorALPAY, HARİKA
dc.contributor.authorsHunter, Kshamta B.; Luecke, Thomas; Spranger, Juergen; Smithson, Sarah F.; Alpay, Harika; Andre, Jean-Luc; Asakura, Yumi; Bogdanovic, Radovan; Bonneau, Dominique; Cairns, Robyn; Cransberg, Karlien; Fruend, Stefan; Fryssira, Helen; Goodman, David; Helmke, Knut; Hinkelmann, Barbara; Lama, Guiliana; Lamfers, Petra; Loirat, Chantal; Majore, Silvia; Mayfield, Christy; Pontz, Bertram F.; Rusu, Cristina; Saraiva, Jorge M.; Schmidt, Beate; Shoemaker, Lawrence; Sigaudy, Sabine; Stajic, Natasa; Taha, Doris; Boerkoel, Cornelius F.
dc.date.accessioned2022-03-14T10:09:47Z
dc.date.accessioned2026-01-11T14:26:15Z
dc.date.available2022-03-14T10:09:47Z
dc.date.issued2010-07
dc.description.abstractSchimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency, and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1. We hypothesized that skeletal features distinguish between those with or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of 22 patients with and 11 without detectable SMARCAL1 mutations. We found that patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED) essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the sella turcica, whereas the hands and other long bones are basically normal. Additionally, we found that several of the adolescent and young adult patients developed osteoporosis and coxarthrosis. Of the 11 patients without detectable SMARCAL1 mutations, seven had a SED indistinguishable from patients with SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with SMARCAL1 mutations and that skeletal features do not distinguish who of those with SED have SMARCAL1 mutations.
dc.identifier.doi10.1007/s00431-009-1115-9
dc.identifier.issn0340-6199
dc.identifier.pubmed20013129
dc.identifier.urihttps://hdl.handle.net/11424/244136
dc.identifier.wosWOS:000278090600005
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofEUROPEAN JOURNAL OF PEDIATRICS
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGenocopy
dc.subjectImmunodeficiency
dc.subjectProteinuria
dc.subjectSkeletal dysplasia
dc.subjectLocus heterogeneity
dc.subjectSchimke immunoosseous dysplasia
dc.subjectIMMUNO-OSSEOUS DYSPLASIA
dc.subjectNEPHROTIC SYNDROME
dc.subjectSPONDYLOEPIPHYSEAL DYSPLASIA
dc.subjectGENE-EXPRESSION
dc.subjectASSOCIATION
dc.subjectSIBLINGS
dc.subjectHELICASE
dc.subjectPROTEIN
dc.titleSchimke immunoosseous dysplasia: defining skeletal features
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage811
oaire.citation.issue7
oaire.citation.startPage801
oaire.citation.titleEUROPEAN JOURNAL OF PEDIATRICS
oaire.citation.volume169

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
909.34 KB
Format:
Adobe Portable Document Format